Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Revvity Inc. (NYSE:RVTY)

Posted by Paula Ricardo on Oct 14th, 2026

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $15,001 and $50,000 in Revvity stock on September 9th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

Purchased $15,001 – $50,000 in shares of Benchmark Electronics (NYSE:BHE) on 10/1/2026.
Sold $1,001 – $15,000 in shares of Oxford Industries (NYSE:OXM) on 9/29/2026.
Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 9/29/2026.
Sold $15,001 – $50,000 in shares of ITT (NYSE:ITT) on 9/29/2026.
Sold $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 9/29/2026.
Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/29/2026.
Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 9/29/2026.
Purchased $1,001 – $15,000 in shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/29/2026.
Purchased $1,001 – $15,000 in shares of YETI (NYSE:YETI) on 9/29/2026.
Sold $1,001 – $15,000 in shares of AtriCure (NASDAQ:ATRC) on 9/29/2026.

Revvity Stock Performance

RVTY stock opened at $155.08 on Wednesday. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $166.25. The stock has a market capitalization of $17.31 billion, a price-to-earnings ratio of 29.09, a PEG ratio of 2.83 and a beta of 1.06. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The stock’s fifty day moving average is $134.17 and its two-hundred day moving average is $112.19.

Revvity (NYSE:RVTY – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. During the same quarter in the prior year, the firm earned $1.18 earnings per share. The company’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, research analysts predict that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is presently 13.33%.

Institutional Investors Weigh In On Revvity

Several institutional investors have recently bought and sold shares of RVTY. Ascentis Independent Advisors acquired a new position in shares of Revvity during the 1st quarter valued at $29,000. Global Retirement Partners LLC bought a new stake in shares of Revvity in the 2nd quarter worth approximately $51,000. SJS Investment Consulting Inc. lifted its stake in Revvity by 5,210.0% during the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock valued at $47,000 after purchasing an additional 521 shares during the last quarter. Summit Securities Group LLC boosted its holdings in Revvity by 294.6% during the first quarter. Summit Securities Group LLC now owns 663 shares of the company’s stock worth $58,000 after buying an additional 495 shares in the last quarter. Finally, Contravisory Investment Management Inc. acquired a new position in Revvity in the first quarter worth approximately $66,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on RVTY. Zacks Research raised shares of Revvity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th. TD Cowen raised their price target on shares of Revvity from $130.00 to $175.00 and gave the company a “buy” rating in a research note on Tuesday. William Blair assumed coverage on Revvity in a report on Monday, October 5th. They set an “outperform” rating on the stock. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Finally, Evercore reissued an “outperform” rating on shares of Revvity in a report on Wednesday, August 5th. Five equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $124.43.

View Our Latest Stock Report on Revvity

Insider Buying and Selling at Revvity

In other news, insider Tajinder Vohra sold 7,330 shares of the stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the completion of the sale, the insider owned 6,635 shares in the company, valued at approximately $934,738.80. This represents a 52.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Maxwell Krakowiak sold 1,631 shares of Revvity stock in a transaction on Monday, September 21st. The stock was sold at an average price of $144.53, for a total value of $235,728.43. Following the completion of the transaction, the insider owned 14,781 shares in the company, valued at $2,136,297.93. The trade was a 9.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 9,130 shares of company stock worth $1,290,745 in the last ninety days. 0.85% of the stock is owned by corporate insiders.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Revvity Company Profile

(Get Free Report)

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.